Celltrion's infliximab biosimilar to be tested for COVID-19

16th June 2020 Uncategorised 0

Infliximab has been chosen because of its effective role in treating autoimmune and inflammatory conditions and established safety profile

More: Celltrion's infliximab biosimilar to be tested for COVID-19
Source: News